|ENZ-Speculation Roumell Asset Management sold out after I sold some of my holdings. However Harbert is increasing it's stake and so am I today. I'm not buying for earnings but for IP. Given the money it has collected for patents.and patent infringement The company must IMO have a good scientific team. This given it's more recent patent portfolio.|
Harbert Management Corp Acquires 63,677 Shares of Enzo Biochem, Inc. (ENZ) Stock Posted by Jim Brewer on May 31st, 2019
Enzo Biochem, Inc. (NYSE:ENZ) major shareholder Harbert Management Corp bought 63,677 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was purchased at an average price of $3.09 per share, with a total value of $196,761.93. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
NYSE:ENZ traded up $0.01 during mid-day trading on Thursday, reaching $3.09. The stock had a trading volume of 61,400 shares, compared to its average volume of 189,872. Enzo Biochem, Inc. has a one year low of $2.32 and a one year high of $6.76. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.38 and a current ratio of 3.83.